2min chapter

Breakpoints cover image

#78 – New Therapies in HIV: The Long Road to Long-acting Antiretrovirals - Are We There Yet?

Breakpoints

CHAPTER

Capri-Pivirin for Viremia and Advanced HIV Diseases

UCSF has given Cabral Pivirin off label to people with Viremia. They would not include it if they had either Rolpivirin or integrase mutations. This is a group of patients who have marginal housing and a lot of substance use disorder and psychiatric illness. 74% received their on time injections, but there was a numerically higher rate of treatment failure with resistance in this population.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode